Displaying 1601 - 1620 of 2591
Phoebe Putney Health System, Inc., Hospital Authority of Albany-Dougherty County, and HCA Inc. Settle FTC Charges that Acquisition of Palmyra Park Hospital Violated U.S. Antitrust Laws
Date
The Federal Trade Commission has entered into a settlement with Phoebe Putney Health System, Inc., the Hospital Authority of Albany-Dougherty County, and HCA Inc. resolving the Commission’s charge...
PepsiCo, Inc., In the Matter of
The Commission required that carbonated soft drink company PepsiCo, Inc. restrict its access to confidential business competitive information of rival Dr Pepper Snapple Group as a condition for proceeding with PepsiCo’s proposed $7.8 billion acquisition of its two largest bottlers and distributors, which also distribute Dr Pepper Snapple Group carbonated soft drinks.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
091 0133
FTC Approves Graco’s Application to Divest Liquid Finishing Business Assets to Carlisle Companies
Date
Following a public comment period, the Federal Trade Commission has approved an application from Graco Inc. to divest certain liquid finishing businesses and related assets to Carlisle Companies Inc...
FTC Approves Final Order Preserving Competition for Generic Antibacterial Drug Minocycline
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Sun Pharmaceutical Industries Ltd.’s $4 billion acquisition of Ranbaxy Laboratories Ltd...
FTC Puts Conditions on Par Petroleum Corporation’s Acquisition of Mid Pac Petroleum, LLC
Date
Texas-based energy company Par Petroleum Corporation will terminate its storage and throughput rights at a key gasoline terminal in Hawaii, to settle Federal Trade Commission charges that Par’s...
Former Bureau of Competition Director Bill Baer and Former FTC Bureau of Consumer Protection Director David Vladeck Named Recipients of 2015 Kirkpatrick Award
Date
Federal Trade Commission Chairwoman Edith Ramirez today named former Bureau of Competition Director William J. Baer and former Bureau of Consumer Protection Director David C. Vladeck the 2015...
Commission Approves Revisions to Its Rules of Practice
Date
The Federal Trade Commission today adopted revisions to the agency’s Rules of Practice. Changes to Part 3 return to the approach of an earlier rule that automatically suspends administrative...
FTC Requires Divestitures in Connection With Impax Laboratories Inc.’s Proposed Acquisition of CorePharma, LLC
Date
Pharmaceutical companies Impax Laboratories Inc. and CorePharma, LLC have agreed to divest all of CorePharma’s rights and assets to generic pilocarpine tablets and generic ursodiol tablets, in order...
FTC Approves Community Health Systems’ Application to Divest Riverview Regional Medical Center to Prime Healthcare
Date
Following a public comment period, the Federal Trade Commission has approved an application from Community Health Systems to sell Riverview Regional Medical Center and its associated assets near...
FTC Approves Final Order Preserving Competition in Market for Treating Heartworm Disease in Dogs
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Eli Lilly and Company’s acquisition of Novartis Animal Health would likely be...
FTC Approves Final Orders Requiring Trade Associations to Eliminate Rules that Restrict Competition
Date
Following a public comment period, the Federal Trade Commission has approved final orders settling charges in two separate cases alleging that the bylaws of the trade associations restrained...
Report
Quarterly Litigation Status Report-March 2015
Date
File
Quarterly Litigation Status Report (March 2015)
(213.03 KB)
FTC Approves Surgery Center Holdings, Inc.’s Application to Divest Assets in Central Florida to Dr. Mark W. Hollmann
Date
Following a public comment period, the Federal Trade Commission has approved an application from the owners of Surgery Center Holdings, known as Surgery Partners to divest Symbion Holdings Corporation...
Statement by FTC Chairwoman Edith Ramirez on U.S. Supreme Court Ruling Regarding North Carolina Dental Board Matter
Date
“Today, the Supreme Court affirmed the FTC's position in recognizing that a state may not give private market participants unsupervised authority to suppress competition even if they act through a...
FTC Puts Conditions on Novartis AG’s Proposed Acquisition of GlaxoSmithKline’s Oncology Drugs
Date
Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma to settle...
Boehringer Ingelheim Pharmaceuticals, Inc.
Type of Action
Process Enforcement
Last Updated
FTC Matter/File Number
091 0182
Case Status
Closed
FTC Challenges Proposed Merger of Sysco and US Foods
Date
Agency Charges Merger Would Create a National Broadline Foodservice Distributor With 75 Percent Market Share, and Harm Customers in Numerous Local Markets
FTC, DOJ Announce Agenda for Joint Public Workshop on Examining U.S. Health Care Competition
Date
The Federal Trade Commission and the U.S. Department of Justice’s Antitrust Division have issued an agenda and posted speaker bios for their joint workshop in the series Examining Health Care...
FTC Approves Merck & Co., Inc.’s Application to Sell Facilities for Manufacturing Heartgard and Heartgard Plus Heartworm Treatments for Dogs to Merial
Date
Following a public comment period, the Federal Trade Commission has approved an application for prior approval from Merck & Co., Inc. to sell its Barcelonata facility to Merial Barceloneta LLC, a...
Displaying 1601 - 1620 of 2591